Cytokinetics
CYTK
CYTK
137 hedge funds and large institutions have $251M invested in Cytokinetics in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.96% more ownership
Funds ownership: 70.71% → 72.66% (+2%)
34% less capital invested
Capital invested by funds: $380M → $251M (-$129M)
43% less call options, than puts
Call options by funds: $314K | Put options by funds: $555K
Holders
137
Holding in Top 10
2
Calls
$314K
Puts
$555K
Top Buyers
| 1 | +$6.28M | |
| 2 | +$3.57M | |
| 3 | +$1.39M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
+$1.11M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$1.11M |
Top Sellers
| 1 | -$6.55M | |
| 2 | -$6.34M | |
| 3 | -$1.29M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.25M |
| 5 |
Millennium Management
New York
|
-$1.2M |